Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Melhem Solh, MD
Blood and Marrow Transplant Group of Georgia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Blood and Marrow Transplant Group of Georgia
Atlanta, Georgia, United States
Recruiting - Northside Hospital
Atlanta, Georgia, United States
Asad Bashey, MD, PhDH. Kent Holland, MDLawrence Morris, MDMelhem Solh, MDScott Solomon, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Sept 2016
- Primary completion
- 31 Aug 2027
- Completion
- 31 Aug 2028
- Last update posted
- 20 Apr 2026
- Registered enrollment
- 20
- Registry id
- NCT02828592
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.